Insights shed light on what the approval means for providers and their patients affected by this neurodegenerative retinal disease
Mohammad Rafieetary, OD, FAAO
Advertisement
Articles by Mohammad Rafieetary, OD, FAAO
Advertisement
Latest Updated Articles
A new era for MacTel: Clinicians react to FDA approval of revakinagene taroretcel-lweyPublished: March 10th 2025 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Looking ahead: Ophthalmologists envision a world without the toughest diseases
2
Study finds no change in smooth pursuit eye movement velocity after 1 season of college football
3
Q&A: Daniela Bacherini discusses using ultra widefield OCT to evaluate peripheral retinal degenerations
4
Increased complications in cataract surgery during the COVID-19 pandemic
5
.png "Optometry Times"){kind=logo}
